Interestingly, phenotypic profiling of immature CD16IntCD44LowCD11bInt LDIBs, whose circulating frequencies are increased in severe COVID-19 patients, has shown that this subpopulation exhibits decreased surface expression of CD44 (29). The gene discussed is CD44; the disease is COVID-19.